跳至主要内容
临床试验/NCT01501123
NCT01501123已完成不适用

Re-hospital Agitation and Sedation Trial: A Randomized Controlled Trial of Haloperidol Versus Midazolam for the Sedation of the Agitated Patient

Catholic Health East1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2011年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
10
试验地点
1
主要终点
Time to sedation

研究概览

简要总结

PREHOSPITAL AGITATION AND SEDATION TRIAL (PHAST)

  • The goal of the PHAST is to demine whether haloperidol is superior to midazolam for the sedation of agitated patients in the prehospital environment
  • The primary outcome is the time to a Richmond Agitation and Sedation Scale (RASS) ≤1

o The RASS is a well validated standardized score to measure a patient's agitation

  • The secondary outcomes are

  • Time until RASS returns to 0 or 1 if RASS <0

  • Need for additional sedation

  • Adverse effects (need for intubation, arrhythmia)

  • Mercy EMS will be the only EMS agency in the Commonwealth of Pennsylvania carrying haloperidol

  • Identification of potential study patients will be per state protocols

  • Exclusion Criteria for the study

  • Age <18

  • Pregnant

  • Allergic to study medication

  • Transport to hospital other than Mercy Fitzgerald Hospital

  • Unable to reach medical command prior to giving medication

  • When a paramedic identifies a possible study candidate, the paramedic will consult medical command to see if the patient is appropriate for the study

  • If the medical command agrees the patient is appropriate for the study, patients will be randomized to

  • Odd days: Haloperidol 5mg IM (age <65) or haloperidol 2.5 mg IM (age ≥65)

  • Even days: Midazolam 0.05 mg IM to maximum of 5mg IM (age <65) or maximum of 2.5mg (age ≥65)

  • The RASS will be documented by the prehospital providers every 5 minutes until arrival at the hospital

  • Once the patient arrives at the ED, the RASS will be documented in PICIS® by the emergency department nurse at the time of triage and at a minimum of hourly until the RASS =0 or 1 for 2 consecutive hours

  • Questions may be directed to Dr. Isenberg at disenberg@mercyhealth.org or at (267) 205-6453

Richmond Agitation Sedation Scale

RASS RASS Description

  • 4 Combative, violent, danger to staff

  • 3 Pulls or removes tube(s) or catheters; aggressive

  • 2 Frequent non-purposeful movement

  • 1 Anxious, apprehensive, but not aggressive 0 Alert and calm

  • 1 Awakens to voice (eye opening/contact) >10 sec

  • 2 Light sedation, briefly awakens to voice (eye opening/contact) <10 sec

  • 3 Moderate sedation, movement or eye opening. No eye contact

  • 4 Deep sedation, no response to voice, but movement or eye opening to physical stimulation

  • 5 Unarousable, no response to voice or physical stimulation

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • Allergic to study medication
  • Transport to hospital other than Mercy Fitzgerald Hospital
  • Unable to reach medical command prior to giving medication

研究组 & 干预措施

Haloperidol

Experimental

IM Haloperidol

干预措施: Haloperidol (Drug)

IM Midazolam

Active Comparator

干预措施: Midazolam (Drug)

结局指标

主要结局

Time to sedation

时间窗: 10 minutes

次要结局

未报告次要终点

研究者

发起方
Catholic Health East
申办方类型
Other
责任方
Principal Investigator
主要研究者

Derek Isenberg

MD

Catholic Health East

研究点 (1)

Loading locations...

相似试验

Pre-hospital Agitation and Sedation Trial: A... | 临床试验